header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-PUB-181010-3
Motor Neuron Abnormalities Correlate with Impaired Movement in Zebrafish that Express Mutant Superoxide Dismutase 1
Robinson, K.J., Yuan, K.C., Don, E.K., Hogan, A.L., Winnick, C.G., Tym, M.C., Lucas, C.W., Shahheydari, H., Watchon, M., Blair, I.P., Atkin, J.D., Nicholson, G.A., Cole, N.J., Laird, A.S.
Date: 2018
Source: Zebrafish   16(1): 8-14 (Journal)
Registered Authors: Cole, Nicholas, Don, Emily, Laird, Angela, Watchon, Maxinne, Winnick, Claire, Yuan, Kristy
Keywords: amyotrophic lateral sclerosis, behavioral testing, chemical screening, motor neuron disease, motor neurons
MeSH Terms:
  • Amyotrophic Lateral Sclerosis/genetics*
  • Amyotrophic Lateral Sclerosis/physiopathology
  • Animals
  • Animals, Genetically Modified/genetics
  • Animals, Genetically Modified/physiology
  • Disease Models, Animal
  • Motor Neurons/physiology*
  • Movement*
  • Mutation*
  • Superoxide Dismutase-1/genetics*
  • Superoxide Dismutase-1/metabolism
  • Zebrafish/physiology*
PubMed: 30300572 Full text @ Zebrafish
FIGURES
ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. ALS can be modeled in zebrafish (Danio rerio) through the expression of human ALS-causing genes, such as superoxide dismutase 1 (SOD1). Overexpression of mutated human SOD1 protein causes aberrant branching and shortening of spinal motor axons. Despite this, the functional relevance of this axon morphology remains elusive. Our aim was to determine whether this motor axonopathy is correlated with impaired movement in mutant (MT) SOD1-expressing zebrafish. Transgenic zebrafish embryos that express blue fluorescent protein (mTagBFP) in motor neurons were injected with either wild-type (WT) or MT (A4V) human SOD1 messenger ribonucleic acid (mRNA). At 48 hours post-fertilization, larvae movement (distance traveled during behavioral testing) was examined, followed by quantification of motor axon length. Larvae injected with MT SOD1 mRNA had significantly shorter and more aberrantly branched motor axons (p < 0.002) and traveled a significantly shorter distance during behavioral testing (p < 0.001) when compared with WT SOD1 and noninjected larvae. Furthermore, there was a positive correlation between distance traveled and motor axon length (R2 = 0.357, p < 0.001). These data represent the first correlative investigation of motor axonopathies and impaired movement in SOD1-expressing zebrafish, confirming functional relevance and validating movement as a disease phenotype for the testing of disease treatments for ALS.
ADDITIONAL INFORMATION